Sunday, February 25, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Massachusetts State Troopers Reinstated After Being Fired for Refusing COVID Shots

Massachusetts state troopers

Seven Massachusetts state troopers who lost their job after refusing to comply with a COVID-19 vaccine mandate, which was ordered by a former governor in 2021, will be reinstated. An independent arbitrator ruled that the fired state troopers be offered their jobs back with full back pay, seniority rights and benefits.1 In August 2021, former […]

Scientific Review Reports Onset Or Worsening of Psoriasis Following COVID Shots

irritated skin

A 2023 scientific review published in the journal Biomedicines reported cases of new onset or worsening of psoriasis following COVID-19 shots.1 Patients in the scientific review either received mRNA-based biologics, including Pfizer/BioNTech Comirnaty or Moderna/NIAID’s Spikevax, or viral vectored vaccines that included AstraZeneca/Oxford University’s Vaxzevria or Johnson & Johnson/Janssen’s Ad26.COV2.S vaccine.2 Psoriasis is a chronic, […]

Meta Review of Autopsies Finds Link Between COVID Shots and Death

autopsy

An independent meta review of autopsies on people who died after COVID-19 vaccination, published as a preprint in The Lancet online on July 5, 2023, found that 74 percent of the deaths were causally related to the shots. The review included 44 published papers that contained 325 autopsy cases and one necropsy case. According to […]

FDA Revokes EUA for Johnson & Johnson/Janssen’s COVID Vaccine

Janssen COVID vaccine

On June 1, 2023, the U.S. Food and Drug Administration (FDA) withdrew the Emergency Use Authorization (EUA) Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S (also known as JNJ-78436735) COVID-19 vaccine that had been granted to the companies on Feb. 27, 2021. The FDA noted that Janssen requested the voluntary withdrawal of the EUA in a letter […]

Guillain-Barré Syndrome Linked to the RSV Vaccine

paralysis in the arm

The potential risk of Guillain-Barré syndrome (GBS) developing after receipt of Pfizer’s respiratory experimental syncytial virus (RSV) vaccine have prompted the U.S. Food and Drug Administration (FDA) to request that Pfizer conduct a post-marketing safety study if the vaccine is approved for use in the United States this spring.1 The RSV vaccine manufactured by GlaxoSmithKline […]

Search in Site

To search in site, type your keyword and hit enter

Search